SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmuLogic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John A. Anderfuren who wrote (1)8/31/1996 10:58:00 AM
From: Paul Getman   of 23
 
IMUL has $75 million in cash as of second quarter 1996. (IMUL's cash is in two places on their balance sheet; $45 million in cash and another $30 in long-term securities.) That should satisfy their cash needs for three years. So they are not facing a cash crunch, nor should they have to go back to the market for funding anytime soon.

I doubt that IMUL will fall to below $7 again, but you can never tell with these things. Biotech stocks are clearly out of favor again, so the valuations are way, way down for the entire group.

Paul
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News